Artwork

内容由Clinical Care Options, LLC and Clinical Care Options提供。所有播客内容(包括剧集、图形和播客描述)均由 Clinical Care Options, LLC and Clinical Care Options 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品,您可以按照此处概述的流程进行操作https://zh.player.fm/legal
Player FM -播客应用
使用Player FM应用程序离线!

CCO Independent Conference Coverage of IDWeek and Glasgow 2024

49:28
 
分享
 

Manage episode 455967370 series 2884624
内容由Clinical Care Options, LLC and Clinical Care Options提供。所有播客内容(包括剧集、图形和播客描述)均由 Clinical Care Options, LLC and Clinical Care Options 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品,您可以按照此处概述的流程进行操作https://zh.player.fm/legal

In this episode, Jean-Michel Molina, MD, PhD, and Joseph J. Eron, Jr., MD, discuss results from key clinical trials on HIV prevention and treatment as well as sexually transmitted infection (STI) prevention presented at IDWeek and Glasgow 2024, including:

  • PURPOSE 1 and 2 comparing lenacapavir injection vs oral TDF/FTC
  • TRIO Health Cohort and OPERA examining long-acting cabotegravir as PrEP
  • DOLCE comparing DTG/3TC as first-line therapy in treatment-naive patients with HIV
  • PRIDOX evaluating the use of DoxyPEP on STI incidence in men who have sex with men on PrEP

Presenters:

Jean-Michel Molina, MD, PhD
Professor of Infectious Diseases
University of Paris Cité
Head of the Department of Infectious Diseases
Hospital Saint-Louis and lariboisière
Paris, France

Joseph J. Eron, Jr., MD
Professor of Medicine, School of Medicine
Herman and Louise Smith Distinguished Professor
Chief, Division of Infectious Diseases
Director, Clinical Core, UNC Center for AIDS Research
Adjunct Professor of Epidemiology, Gillings School of Global Public Health
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina

Link to full program:
https://bit.ly/3BBaZvJ

  continue reading

424集单集

Artwork
icon分享
 
Manage episode 455967370 series 2884624
内容由Clinical Care Options, LLC and Clinical Care Options提供。所有播客内容(包括剧集、图形和播客描述)均由 Clinical Care Options, LLC and Clinical Care Options 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品,您可以按照此处概述的流程进行操作https://zh.player.fm/legal

In this episode, Jean-Michel Molina, MD, PhD, and Joseph J. Eron, Jr., MD, discuss results from key clinical trials on HIV prevention and treatment as well as sexually transmitted infection (STI) prevention presented at IDWeek and Glasgow 2024, including:

  • PURPOSE 1 and 2 comparing lenacapavir injection vs oral TDF/FTC
  • TRIO Health Cohort and OPERA examining long-acting cabotegravir as PrEP
  • DOLCE comparing DTG/3TC as first-line therapy in treatment-naive patients with HIV
  • PRIDOX evaluating the use of DoxyPEP on STI incidence in men who have sex with men on PrEP

Presenters:

Jean-Michel Molina, MD, PhD
Professor of Infectious Diseases
University of Paris Cité
Head of the Department of Infectious Diseases
Hospital Saint-Louis and lariboisière
Paris, France

Joseph J. Eron, Jr., MD
Professor of Medicine, School of Medicine
Herman and Louise Smith Distinguished Professor
Chief, Division of Infectious Diseases
Director, Clinical Core, UNC Center for AIDS Research
Adjunct Professor of Epidemiology, Gillings School of Global Public Health
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina

Link to full program:
https://bit.ly/3BBaZvJ

  continue reading

424集单集

Semua episode

×
 
Loading …

欢迎使用Player FM

Player FM正在网上搜索高质量的播客,以便您现在享受。它是最好的播客应用程序,适用于安卓、iPhone和网络。注册以跨设备同步订阅。

 

快速参考指南

边探索边听这个节目
播放